Psyence Group Eulerpool News

Psyence Group Eulerpool News

Psyence Group Aktie News

Psyence Group wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Psyence Group News stellen wir hier zusammen.

• 18. September ·

  Yahoo
  Psyence Group's NASDAQ-Listed Associate, Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones
• 16. September ·

  Yahoo
  Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care
• 26. Juli ·

  Yahoo
  Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trial
• 16. April ·

  Yahoo
  Psyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
• 26. März ·

  Yahoo
  Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
• 12. März ·

  Yahoo
  Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
• 11. März ·

  Yahoo
  Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division
• 26. Januar ·

  Yahoo
  Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp
• 16. Januar ·

  Yahoo
  Psyence Group Inc Subsidiary Psyence Biomedical Ltd. announces signing of definitive agreement for a convertible note in connection with planned business combination
• 20. November ·

  Yahoo
  Psyence Group Announces Resignation of Board Member